Not applicableStudy completedNCT00550329What this trial is testingBioequivalence Study Of Glucotrol XL 2.5 Mg TabletsWho this might be right forDiabetes Mellitus, Non-Insulin-DependentHyperglycemia Pfizer 32
Early research (Phase 1)Not Yet RecruitingNCT06492655What this trial is testingTo Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy VolunteersWho this might be right forType 2 Diabetes Mellitus Chong Kun Dang Pharmaceutical 28
Early research (Phase 1)Study completedNCT02373150What this trial is testingSafety, Tolerability and PK of Imeglimin in Japanese VolunteersWho this might be right forType 2 Diabetes Mellitus Poxel SA 48
Early research (Phase 1)Study completedNCT02685774What this trial is testingA Clinical Study to Compare the Pharmacokinetic Characteristics of CKD-395 0.25/500mg in Healthy Male VolunteersWho this might be right forDiabetes Mellitus, Type II Chong Kun Dang Pharmaceutical 26
Early research (Phase 1)Study completedNCT00562250What this trial is testingPharmacokinetic Drug Interaction Study With Dapagliflozin and Glimepiride in Healthy SubjectsWho this might be right forDiabetes Mellitus, Type 2 AstraZeneca 11
Early research (Phase 1)Study completedNCT00501397What this trial is testingThe Effects of Ketoconazole Taken Orally Has on the PK Profiles of a Dose of GSK189075 in Healthy VolunteersWho this might be right forType 2 Diabetes MellitusDiabetes Mellitus, Type 2 GlaxoSmithKline 22
Early research (Phase 1)Study completedNCT04970940What this trial is testingThe Drug-drug Interaction Study of AJU-A51R1 and AJU-A51R2Who this might be right forT2DM (Type 2 Diabetes Mellitus) AJU Pharm Co., Ltd. 30
Early research (Phase 1)Study completedNCT01433380What this trial is testingEvaluate PF-05175157 In Healthy VolunteersWho this might be right forDiabetes Mellitus, Type 2 Pfizer 22
Early research (Phase 1)Study completedNCT01571661What this trial is testingA First-time-in-human Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of GSK189075A in Healthy Subjects and in Subjects With Type 2 Diabetes MellitusWho this might be right forDiabetes Mellitus, Type 2 GlaxoSmithKline 16
Early research (Phase 1)Study completedNCT03776227What this trial is testingA Bioequivalence Study Testing Two Formulations of Sotagliflozin in Healthy Male and Female Subjects Under Fasted ConditionsWho this might be right forType 2 Diabetes MellitusHealthy Subjects Sanofi 66
Early research (Phase 1)Study completedNCT05274880What this trial is testingStudy to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393Who this might be right forType II Diabetes Mellitus Chong Kun Dang Pharmaceutical 28
Testing effectiveness (Phase 2)Study completedNCT01845064What this trial is testingEvaluate the Safety and Effectiveness of DM199 in Healthy Subjects and Type 2 Diabetes PatientsWho this might be right forDiabetes Type 2 DiaMedica Therapeutics Inc 98
Early research (Phase 1)Study completedNCT05409924What this trial is testingFirst-in-human Single and Multiple Dose Trial of ATR-258Who this might be right forType 2 Diabetes Mellitus Atrogi AB 71
Not applicableUnknownNCT02023489What this trial is testingLipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor MutationsWho this might be right forType 2 Diabetes MellitusPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Familiar Hypocalcuric Hypercalcemia+2 more Medical University of Vienna 90
Early research (Phase 1)Study completedNCT05983289What this trial is testingSingle Escalating Dose Study Of HSK7653 In Healthy SubjectsWho this might be right forT2DM (Type 2 Diabetes Mellitus) Haisco Pharmaceutical Group Co., Ltd. 62
Early research (Phase 1)Study completedNCT05459285What this trial is testingA Pharmacokinetic Study Comparing the 14028 Injection and TRULICITY® in Healthy Chinese SubjectsWho this might be right forType 2 Diabetes Sunshine Lake Pharma Co., Ltd. 68
Not applicableStudy completedNCT03976271What this trial is testingConsequences of Hypoglycaemia on Cardiovascular and Inflammatory ResponsesWho this might be right forHypoglycemiaInflammatory ResponseDiabetes Mellitus, Type 1+1 more Radboud University Medical Center 110
Early research (Phase 1)Study completedNCT06293742What this trial is testingECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy ParticipantsWho this might be right forType 2 Diabetes Mellitus Eccogene 48
Early research (Phase 1)WithdrawnNCT01305551What this trial is testingBE Study of the Fixed Dose Combination of 5 mg Saxagliptin and 500 mg Metformin HCl XR Tablet Relative to a 5 mg Saxagliptin (Onglyza™) Tablet and a 500 mg Metformin HCl XR (Glifage® XR Marketed in Brazil by Merck S.A.) Tablet Co-Administered to Healthy Subjects in the Fasted and Fed StatesWho this might be right forType 2 Diabetes AstraZeneca
Early research (Phase 1)Study completedNCT05682495What this trial is testingA HR20031 BE Study on Healthy SubjectsWho this might be right forType 2 Diabetes Shandong Suncadia Medicine Co., Ltd. 96